The Journal of Headache and Pain (Jun 2024)

The burden of headache and a health-care needs assessment in the adult population of Mali: a cross-sectional population-based study

  • Youssoufa Maiga,
  • Seybou H. Diallo,
  • Oumar Sangho,
  • Leon Samuel Moskatel,
  • Fatoumata Konipo,
  • Abdoulaye Bocoum,
  • Salimata Diallo,
  • Awa Coulibaly,
  • Mariam Daou,
  • Housseini Dolo,
  • Modibo Sangaré,
  • Mohamed Albakaye,
  • Zoumana Traoré,
  • Thomas Coulibaly,
  • Adama Sissoko,
  • Guida Landouré,
  • Boubacar Guindo,
  • Mahamoudou Ahamadou,
  • Mahamane Drahamane Toure,
  • Abibatou Dembele,
  • Habib Sacko,
  • Cheick Abdoul Kadri Sao,
  • Diakalia Coulibaly,
  • Salimata Dembele,
  • Cheick Oumar Coulibaly,
  • Mohamadou Sanogo,
  • Sekou Boiguilé,
  • Julien Nizard,
  • Robert Cowan,
  • Timothy J. Steiner,
  • and Andreas Husøy

DOI
https://doi.org/10.1186/s10194-024-01811-5
Journal volume & issue
Vol. 25, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background Our recent studies have shown headache disorders to be very common in the central and western sub-Saharan countries of Benin and Cameroon. Here we report headache in nearby Mali, a strife-torn country that differs topographically, culturally, politically and economically. The purposes were to estimate headache-attributed burden and need for headache care. Methods We used cluster-random sampling in seven of Mali’s eleven regions to obtain a nationally representative sample. During unannounced household visits by trained interviewers, one randomly selected adult member (18–65 years) from each household was interviewed using the structured HARDSHIP questionnaire, with enquiries into headache in the last year and, additionally, headache yesterday (HY). Headache on ≥ 15 days/month (H15+) was diagnosed as probable medication-overuse headache (pMOH) when associated with acute medication use on ≥ 15 days/month, and as “other H15+” when not. Episodic headache (on < 15 days/month) was recorded as such and not further diagnosed. Burden was assessed as impaired participation (days lost from paid and household work, and from leisure activity). Need for headache care was defined by criteria for expectation of benefit. Results Data collection coincided with the SARS-CoV-2 pandemic. The participating proportion was nonetheless extremely high (99.4%). The observed 1-year prevalence of any headache was 90.9%. Age- and gender-adjusted estimates were 86.3% for episodic headache, 1.4% for pMOH and 3.1% for other H15+. HY was reported by 16.8% with a mean duration of 8.7 h. Overall mean headache frequency was 3.5 days/month. Participants with pMOH lost more days from paid (8.8 days/3 months) and household work (10.3 days/3 months) than those with other H15+ (3.1 and 2.8 days/3 months) or episodic headache (1.2 and 0.9 days/3 months). At population level, 3.6–5.8% of all time was spent with headache, which led to a 3.6% decrease in all activity (impaired participation). Almost a quarter (23.4%) of Mali’s adult population need headache care. Conclusion Headache is very common in Mali, as in its near neighbours, Benin and Cameroon, and associated with substantial losses of health and productivity. Need for headache care is high – a challenge for a low-income country – but lost productivity probably translates into lost gross domestic product.

Keywords